Korean Reinsurance Company:企業の戦略・SWOT・財務情報

◆英語タイトル:Korean Reinsurance Company - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C3980
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥22,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥45,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥68,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Korean Reinsurance Company – Strategy, SWOT and Corporate Finance Report
Summary

Korean Reinsurance Company – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Korean Reinsurance Company (Korean Re) is a provider of life and non-life reinsurance products. It offers reinsurance products for property, marine, aviation, engineering, casualty, museum, and inland floater. It also offers general liability reinsurance, professional liability reinsurance, workers’ compensation reinsurance, personal accident reinsurance, guarantee reinsurance and other specialty reinsurance. It also offers reinsurance solutions for whole life, term, critical illness, cancer, long term care, accident and juvenile. It offers products and services to insurance companies across the world. The company, through its subsidiaries, liaison offices and branches, has operations in the UK, Japan, South Korea, the US, China, the UAE, Hong Kong, Singapore and Malaysia. Korean Re is headquartered in Seoul, South Korea.

The company reported gross written premiums of KRW7,208.1 billion for the fiscal year ended December 2017 (FY2017), an increase of 7.8% over that in FY2016. Its net written premiums were KRW5,021.8 billion in FY2017, an increase of 6.9% over that in FY2016.

Scope

- Detailed information on Korean Reinsurance Company required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Korean Reinsurance Company in the form of a SWOT analysis
- An in-depth view of the business model of Korean Reinsurance Company including a breakdown and examination of key business segments
- Intelligence on Korean Reinsurance Company’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Korean Reinsurance Company, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Korean Reinsurance Company and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Korean Reinsurance Company as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Korean Reinsurance Company’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Korean Reinsurance Company: Company Overview 6
Korean Reinsurance Company: Overview and Key Facts 6
Korean Reinsurance Company: Overview 6
Korean Reinsurance Company: Key Facts 6
Korean Reinsurance Company: Key Employees 8
Korean Reinsurance Company: Key Employee Biographies 9
Korean Reinsurance Company: Major Products and Services 10
Korean Reinsurance Company: Company History 11
Korean Reinsurance Company: Management Statement 13
Korean Reinsurance Company: Locations and Subsidiaries 14
Korean Reinsurance Company: Key Competitors 15
Korean Reinsurance Company: Company Analysis 16
Korean Reinsurance Company: Business Description 16
Korean Reinsurance Company: SWOT Analysis 18
Korean Reinsurance Company: SWOT Overview 18
Korean Reinsurance Company: Strengths 18
Korean Reinsurance Company: Weaknesses 19
Korean Reinsurance Company: Opportunities 19
Korean Reinsurance Company: Threats 19
Korean Reinsurance Company: Recent Developments 21
Korean Reinsurance Company: News and Events Summary 21
Korean Reinsurance Company: Financial Performance 21
Korean Reinsurance Company: Regulatory and Legal Events 21
Appendix 23
Contact Us 23
Methodology 23
About MarketLine 24

List of Tables
Table 1: Korean Reinsurance Company: Key Facts
Table 2: Korean Reinsurance Company: Key Employees
Table 3: Korean Reinsurance Company: Locations and Subsidiaries
Table 4: Korean Reinsurance Company: Key Competitors
Table 5: Korean Reinsurance Company: News and Events Summary
Table 6: Korean Reinsurance Company: Financial Performance
Table 7: Korean Reinsurance Company: Regulatory and Legal Events



★海外企業調査レポート[Korean Reinsurance Company:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Enterprise Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Enterprise Therapeutics Ltd (Enterprise Therapeutics) is a drug discovery company that offers research and development of novel therapies for the treatment of respiratory diseases. The company also identifies novel targets and compounds which reduces the mucus production. It provides therape …
  • REV Group Inc (REVG):企業の財務・戦略的SWOT分析
    REV Group Inc (REVG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Beacon Biomedical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Beacon Biomedical Inc (Beacon) is a medical diagnostic device company that offers point-of-care blood test systems. The company offers its product portfolio in the therapeutic areas of breast cancer, colorectal cancer and lung cancer. It holds two patented technologies such as signaling prot …
  • EndoGastric Solutions Inc-製薬・医療分野:企業M&A・提携分析
    Summary EndoGastric Solutions Inc (EGS), formerly EsophyX, Inc. is a medical equipment company that manufactures and markets gastroenterology and surgical products. The company’s products include esophy-x device and serosa-fuse fasteners. Its esophy-x device is used in reconstructing the gastroesoph …
  • Grunenthal GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Grunenthal GmbH (Grunenthal) is a research-oriented pharmaceutical company. It researches, develops, produces and markets products for the treatment of pain and innovative formulations of established active substances. The company provides new chemical entities including opioids for moderate …
  • Genedrive Plc (GDR):企業の製品パイプライン分析
    Summary Genedrive Plc (Genedrive), formerly Epistem Holdings plc, develops and markets point of need molecular diagnostics platform for identifying infectious diseases and pathogens and providing other indications. The Genedrive HCVID test is the company’s CE-IVD certified molecular diagnostics plat …
  • Provectus Biopharmaceuticals Inc (PVCT):製薬・医療:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Hochdorf Holding AG (HOCN):企業の財務・戦略的SWOT分析
    Hochdorf Holding AG (HOCN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Oil India Ltd (OIL):企業の財務・戦略的SWOT分析
    Oil India Ltd (OIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Meijer Inc:戦略・SWOT・企業財務分析
    Meijer Inc - Strategy, SWOT and Corporate Finance Report Summary Meijer Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Condor Petroleum Inc (CPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Condor Petroleum Inc. (Condor) is an independent upstream oil and gas company. The company through its subsidiaries, acquires, explores, produces and markets oil and gas. It has operational presence in Kazakhstan and Turkey. The company operates on the Pre-Caspian basin, a prolific region th …
  • Bellco Srl:医療機器:M&Aディール及び事業提携情報
    Summary Bellco Srl (Bellco), a subsidiary of Medtronic plc, is a biotechnology company that offers hemodialysis solutions. The company provides chronic line, acute line and neonatal patient products. Its chronic line products comprise haemodiafiltration therapies and dialysis machines, among others. …
  • Suntory Holdings Ltd:企業の戦略・SWOT・財務情報
    Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hero AG:企業の戦略・SWOT・財務分析
    Hero AG - Strategy, SWOT and Corporate Finance Report Summary Hero AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Shenzhen Salubris Pharmaceuticals Co Ltd (002294):製薬・医療:M&Aディール及び事業提携情報
    Summary Shenzhen Salubris Pharmaceuticals Co Ltd (Salubris) is a pharmaceutical company that research, develops, manufactures and distributes pharmaceutical and healthcare products. The company produces tablet, capsule, and injection formulations and active pharmaceutical ingredients, among others. …
  • UGI Corporation (UGI)-石油・ガス分野:企業M&A・提携分析
    Summary UGI Corporation (UGI) is a holding company providing energy products and services. Through a network of subsidiaries, the company stores, transports, distributes and markets energy products and related services. It serves as a domestic and international retail distributor of propane and buta …
  • EyeGate Pharmaceuticals Inc (EYEG)-製薬・医療分野:企業M&A・提携分析
    Summary EyeGate Pharmaceuticals Inc (EyeGate) is a clinical-stage specialty pharmaceutical company that offers eye care medicines. The company offers macular edema and non-infectious anterior uveitis. It offers technologies for most prevalent issues in ophthalmic care; the existing lack of patient a …
  • Andhra Pradesh Power Generation Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary Andhra Pradesh Power Generation Corporation Limited (APGENCO) is a state-owned electricity utility that that conducts the generation, operation, maintenance and execution of energy projects. The company owns, operates, and maintains thermal, hydel and wind power plants. APGENCO also undertak …
  • Santee Cooper:電力:M&Aディール及び事業提携情報
    Summary Santee Cooper (Santee), formerly South Carolina Public Service Authority, is a state-owned electric and water utility. The company generates the electricity from coal, natural gas, nuclear, hydro, biomass, landfill, and solar sources. It purchases, sells, and exchanges energy with other bulk …
  • Patrys Ltd (PAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Patrys Ltd (Patrys) is a therapeutic antibody development company focused on IgM antibodies and IgG antibody fragments in the field of oncology. The company's pipeline products include PAT-SC1 an immunoglobulin M (IgM) type antibody used for the treatment of gastric cancer; PAT-SM6 is a full …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆